belcesiran
Generic: DCR-A1AT·Code: DCR-A1AT
belcesiran: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Dicerna Pharmaceuticals Inc (DRNA) | Phase 2 |
Clinical Trials (1)
A Phase 2, Randomized, Double-blind, Placebo-Controlled Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Dose Levels of Belcesiran in Patients With Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
Frequently asked questions
Who is developing belcesiran?
belcesiran is being developed by Dicerna Pharmaceuticals Inc.
How many clinical trials involve belcesiran?
BioSniper tracks 1 clinical trial involving belcesiran.
Get deeper analysis on belcesiran
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis